Antibe Therapeutics Inc (TSX:ATE)
C$ 0.295 0 (0%) Market Cap: 15.64 Mil Enterprise Value: -39.17 Mil PE Ratio: 0 PB Ratio: 0.60 GF Score: 37/100

Antibe Therapeutics Inc (TSX:ATE) Stock Estimates Data

Antibe Therapeutics Inc (TSX:ATE) 12 Month Price Targets

Antibe Therapeutics Inc (TSX:ATE) Analyst Rating